4D Molecular Therapeutics, Inc. 10-Q

Accession 0000950170-21-004086

Filing information

CIK: 0001650648
Report date: 2021-09-30
Filing date: 2021-11-10
Form: 10-Q
Primary document: fdmt-20210930.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.